Garenoxacin versus Levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology
Phase of Trial: Phase IV
Latest Information Update: 30 Apr 2018
Price : $35 *
At a glance
- Drugs Garenoxacin (Primary) ; Levofloxacin
- Indications Rhinosinusitis
- Focus Therapeutic Use
- 25 Apr 2018 Status changed from recruiting to completed.
- 02 Jun 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 05 Dec 2013 New trial record